Michael S Hearne La Jolla Pharmaceutical CO (LJPC) insider trading activity

LJPC Quotes by TradingView

Michael S Hearne is Chief Financial Officer of LA JOLLA PHARMACEUTICAL CO. Currently has a direct ownership of 0 shares of LJPC, which is worth approximately $0. The most recent transaction as insider was on Aug 22, 2022, when has been sold 10,186 shares (Common Stock) at a price of $6.23 per share, resulting in proceeds of $63,459. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Michael S Hearne Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 22 2022
SELL
Sale (or disposition) back to the issuer
$63,459 $6.23 p/Share
10,186 Reduced 100.0%
0 Common Stock
Jun 30 2022
BUY
Grant, award, or other acquisition
$640 $2.71 p/Share
236 Added 2.26%
10,186 Common Stock
Jun 15 2022
BUY
Grant, award, or other acquisition
$642 $2.72 p/Share
236 Added 2.32%
9,950 Common Stock
May 31 2022
BUY
Grant, award, or other acquisition
$644 $3.41 p/Share
189 Added 1.91%
9,714 Common Stock
May 13 2022
BUY
Grant, award, or other acquisition
$641 $3.41 p/Share
188 Added 1.94%
9,525 Common Stock
Apr 29 2022
BUY
Grant, award, or other acquisition
$642 $3.47 p/Share
185 Added 1.94%
9,337 Common Stock
Apr 14 2022
BUY
Grant, award, or other acquisition
$642 $3.71 p/Share
173 Added 1.86%
9,152 Common Stock
Mar 31 2022
BUY
Grant, award, or other acquisition
$643 $3.63 p/Share
177 Added 1.93%
8,979 Common Stock
Mar 15 2022
BUY
Grant, award, or other acquisition
$640 $3.37 p/Share
190 Added 2.11%
8,802 Common Stock
Feb 28 2022
BUY
Grant, award, or other acquisition
$644 $3.48 p/Share
185 Added 2.1%
8,612 Common Stock
Feb 15 2022
BUY
Grant, award, or other acquisition
$641 $3.79 p/Share
169 Added 1.97%
8,427 Common Stock
Jan 31 2022
BUY
Grant, award, or other acquisition
$6,600 $3.94 p/Share
1,675 Added 16.86%
8,258 Common Stock
Jan 14 2022
BUY
Grant, award, or other acquisition
$619 $4.18 p/Share
148 Added 2.2%
6,583 Common Stock
Dec 30 2021
BUY
Grant, award, or other acquisition
$615 $3.92 p/Share
157 Added 2.38%
6,435 Common Stock
Dec 15 2021
BUY
Grant, award, or other acquisition
$619 $3.58 p/Share
173 Added 2.68%
6,278 Common Stock
Nov 30 2021
BUY
Grant, award, or other acquisition
$616 $3.31 p/Share
186 Added 2.96%
6,105 Common Stock
Nov 15 2021
BUY
Grant, award, or other acquisition
$617 $3.41 p/Share
181 Added 2.97%
5,919 Common Stock
Oct 29 2021
BUY
Grant, award, or other acquisition
$619 $3.42 p/Share
181 Added 3.06%
5,738 Common Stock
Oct 15 2021
BUY
Grant, award, or other acquisition
$617 $3.37 p/Share
183 Added 3.19%
5,557 Common Stock
Sep 30 2021
BUY
Grant, award, or other acquisition
$617 $3.39 p/Share
182 Added 3.28%
5,374 Common Stock
Sep 15 2021
BUY
Grant, award, or other acquisition
$1,851 $3.39 p/Share
546 Added 9.52%
5,192 Common Stock
Jul 30 2021
BUY
Grant, award, or other acquisition
$617 $3.07 p/Share
201 Added 4.15%
4,646 Common Stock
Jul 15 2021
BUY
Grant, award, or other acquisition
$618 $3.2 p/Share
193 Added 4.16%
4,445 Common Stock
Jun 30 2021
BUY
Grant, award, or other acquisition
$619 $3.64 p/Share
170 Added 3.84%
4,252 Common Stock
Jun 15 2021
BUY
Grant, award, or other acquisition
$617 $4.17 p/Share
148 Added 3.5%
4,082 Common Stock

Also insider at

ODTC
Odonate Therapeutics, Inc. Financial Services
Chief Financial Officer
MSH

Michael S Hearne

Chief Financial Officer
Waltham, MA

Track Institutional and Insider Activities on LJPC

Follow LA JOLLA PHARMACEUTICAL CO and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LJPC shares.

Notify only if

Insider Trading

Get notified when an La Jolla Pharmaceutical CO insider buys or sells LJPC shares.

Notify only if

News

Receive news related to LA JOLLA PHARMACEUTICAL CO

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LJPC